sellModerate cluster of 3
Christopher Heery sold $648k of ACLX
CHIEF MEDICAL OFFICER at Arcellx, Inc.. 10,155 shares at an average of $63.79, traded Feb 24, 2025, filed Feb 24, 2025.
Warning score
40Value
$648k
10,155 shares
Holdings after
37,486
-21% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +20Trade size$648k at market
- +5Share of holdings soldSold 21% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-25-005369, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 7, 2025 | MOption exercise Common Stock | +22,556 | $0.00 | $0 | 47,641 | Feb 24, 2025 |
| Feb 24, 2025 | SOpen-market sale Common Stock | -4,370 | $63.14 | $276k | 43,271 | Feb 24, 2025 |
| Feb 24, 2025 | SOpen-market sale Common Stock | -5,577 | $64.26 | $358k | 37,694 | Feb 24, 2025 |
| Feb 24, 2025 | SOpen-market sale Common Stock | -208 | $64.88 | $13k | 37,486 | Feb 24, 2025 |
| Feb 7, 2025 | MOption exercise Restricted Stock Unitderivative | -22,556 | $0.00 | $0 | 0 | Feb 24, 2025 |
Related signals
Other insiders at Arcellx, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | Arcellx, Inc. | Christopher Heery CHIEF MEDICAL OFFICER | $1.7M 21,034 shares | -97% | |
| 0Weak | Arcellx, Inc. | Christopher Heery CHIEF MEDICAL OFFICER | $5,852 73 shares | -0% | |
| 30Weak | Arcellx, Inc. | Christopher Heery CHIEF MEDICAL OFFICER | $993k 12,396 shares | -36% | |
| 9Weak | Arcellx, Inc. | Christopher Heery CHIEF MEDICAL OFFICER | $291k 3,643 shares | -10% | |
| 18Weak | Arcellx, Inc. | Kavita Patel director | $101k 1,500 shares | -100% | |
| 47Moderate | Arcellx, Inc. | Michelle Gilson CHIEF FINANCIAL OFFICER | $785k 12,235 shares | -38% | |
| 17Weak | Arcellx, Inc. | Kavita Patel director | $88k 1,500 shares | -100% | |
| 10Weak | Arcellx, Inc. | Kavita Patel director | $96k 1,500 shares | -100% | |
| 9Weak | Arcellx, Inc. | Kavita Patel director | $86k 1,500 shares | -100% | |
| 10Weak | Arcellx, Inc. | Kavita Patel director | $107k 1,500 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.